「FOLFIRINOX as first-line chemotherapy in Japanese patients suffering from metastatic pancreatic cancer (KOBE FOLFIRINOX Study)」の関連論文
-
Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study.
-
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study
-
Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer : A Case Report.
-
Real‑world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real‑world data project
-
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
-
Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study
-
Efficacy and safety of neoadjuvant chemoradiation therapy administered for 5 versus 2 weeks for resectable and borderline resectable pancreatic cancer
-
Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma
-
転移性尿路上皮癌に対するGC療法における, Gemcitabine投与後の発熱の臨床的意義の検討: 多施設共同後ろ向き研究
-
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
-
Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases : A retrospective multicenter study
-
Association of sunitinib concentration and clinical outcome in patients with metastatic renal cell carcinoma treated with a 2-week-on and 1-week-off schedule
-
Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review
-
三次治療のGemcitabine・Paclitaxel療法が著効した進行性膀胱癌の1例
-
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
-
Optimized radiotherapy treatment strategy for early glottic carcinoma
-
Finding potential synergistic drugs to reduce chemo-resistance for the treatment of highly malignant tumors in female
-
Impact of thoracic esophageal displacement after lobectomy on the continuity of oral adjuvant chemotherapy.
-
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer
-
Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
-
Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
7. Neutron Capture Therapy
-
Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review
-
Chemotherapy for biliary tract cancer: real-world experience in a single institute
-
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
-
Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure
-
MYC Upregulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer
-
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
-
Efficacy of Combination Treatment with Tadalafil and Mirabegron in Patients with Benign Prostatic Hyperplasia Who Presented with Persistent Storage Symptoms After Tadalafil Monotreatment: A Prospective, Multicenter, Open-Labeled Study
-
Comparison of efficacy and safety outcomes of anticancer drugs between Japanese patients and the overall population in multi-regional clinical trials
-
Effectiveness of tolvaptan and long-term prognosis in patients with liver cirrhosis
-
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients (本文)
-
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients
-
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome
-
Neutrophil–lymphocyte Ratio and Histological Response Correlate With Prognosis of Gastric Cancer Undergoing Neoadjuvant Chemotherapy
-
Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study
-
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
-
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
-
Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer.
-
母集団薬物動態モデリング&シミュレーションによる抗微生物薬の個別化投与設計に関する研究
-
Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma
-
前立腺癌に対する強度変調放射線治療における晩期直腸有害事象の発生予測因子
-
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial
-
Dual-alkylator Conditioning Regimen with Busulfan and Melphalan for Bone Marrow Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis : The Results of a Retrospective Study at a Single Institution in Japan
-
Urine volume to hydration volume ratio is associated with pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma.
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer
-
Relationship between stromal regulatory T cells and the response to neoadjuvant chemotherapy for locally advanced rectal cancer
-
分子標的薬時代における転移性腎癌の腫瘍縮小率が予後に与える影響